Bayer to Purchase Cydectin Line From Boehringer Ingelheim

Bayer to Purchase Cydectin Line From Boehringer Ingelheim

Bovine Veterinarian

Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) this week announced that they have signed an agreement under which, on completion of the transaction, Bayer would acquire BIVI’s CYDECTIN bovine and ovine endectocide products in the U.S.

Full Story

Comments are closed.